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Summary: It was studied the assortment of soft medications with corticosteroids used in dermatology. It was found the 
correlation of domestic and foreign medications within each pharmacotherapeutic subgroup of medications. The price 
range was analyzed and the liquidity ratio for medications in this category was calculated too.
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Introduction. Every year the level of skin disease is 
growing rapidly. Today soft medications (SM) take the 
 rst place for the local treatment of dermatological dis-
eases [1, 2]. SM with corticosteroids (CS) are the most 
commonly used medications in dermatology. This group 
of medications (M) for over 50 years is used for treat-
ment of dermatitis, eczema, erythema, psoriasis, for re-
lieving symptoms of in ammation and itching of the skin 
[3]. The therapeutic effect of these medications is due to 
their anti-in ammatory, antihistamine and vasoconstric-
tor action. 
However, the price is one of the constituent elements 
of pharmaceutical marketing and one of the most im-
portant factors determining the choice of buyers and 
demand for goods [4]. Taking into consideration, that 
CS belong to high-cost medications, the analysis of 
registered medications at the pharmaceutical market of 
Ukraine and price monitoring are actual issues.
The aim of research was to study the index of medi-
cation assortment with corticosteroids, summarize the 
results of price analysis, namely: the calculation of aver-
age retail prices of medications, liquidity ratios of prices, 
which were analyzed with the following justi cation of 
general trends.
Research methods. The object of the study was the 
information posted on the website «Regulatory and leg-
islative documents of the Ministry of Health of Ukraine» 
[5] about registered SM in Ukraine and the method of 
analysis of used secondary marketing information. The 
electronic on-line directory «Compendium» [6] was used 
as an information source. The system-viewing method, 
graphic, documentary and marketing methods were 
used for the research.
Results and discussion. There has been 492 names 
registered, of which 226 medications are used in derma-
tology according to preliminary studies, for the date of 
January 1, 2015.
The largest number of registered medicines belongs 
to the group of medications with corticosteroids (D 07), 
80 medications are used in dermatology. According to 
the order No. 235 «classi er dosage forms» [7] of MPH 
of Ukraine, all registered medications with CS were di-
vided due to their dosage form into creams, ointments, 
gels, pastes, liniments (Fig. 1).
Fig. 1. The assortment of SM with corticosteroids considering the type of dosage form
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Thus, in the ratio ointments and creams have 49.43 
% of the assortment, gels only 1.15 % and corticosteroid 
medications such as liniments and pastes are not repre-
sented on the pharmaceutical market of Ukraine.
The domestic market of SM with CS depends on import 
because soft dosage forms (SDF) of foreign manufacturing 
take 73.56 % of assortment, while soft dosage forms (SDF) 
of domestic production have 26.44 % of the market.
SM with CS are represented by 12 countries of the 
world at Ukrainian market, the leaders are: Poland – 
21.87 %, India – 14.06 %, Italy – 12.5 %, Germany – 
10.93 %, Belgium and Croatia – 9,37 % each. Other 
countries, import of which is not higher than 5 medica-
tions, occupy 21.90 % of the Ukrainian market of SDF.
In Ukraine, SM with corticosteroids are produced by 8 
pharmaceutical enterprises of different ownership. Lead-
ing manufacturing positions are occupied by Pharma-
ceutical Company Zdoroviya, LLC – 26.08 %, Farmak, 
PJSC, Pharmaceutical company Darnytsiya, PJSC and 
Kievmedpreparat, PJSC have 17.39 % each of pharma-
ceutical market. Other pharmaceutical companies that 
have production of soft dosage forms with CS no more 
than 3 medications occupy 21.75 % of the market.
Price is one of the most important elements of the 
marketing complex because it determines the monetary 
price paid for a particular product [8]. 
Price features of SDF with CS presented at the do-
mestic wholesale market from January 2015 to May 
2015 were investigated during the research. In particu-
lar, dynamics of changes, average weighted wholesale 
price and liquidity ratios were studied. Wholesale prices 
presented on an electronic resource «Ezhenedelnyk 
apteky» [9] were used for the analysis.
We analyzed the pricing environment of SDF with CS 
and de ned liquidity ratio, which has showed the bal-
ance between the maximum and minimum price of a 
particular medication at a current period at the appropri-
ate market [4] for this category of medications of soft 
dosage form during January – May 2015 (Fig. 2).
6.89 % of medications of soft dosage forms with CS 
have liquidity ratio less than 0,15, it may indicate that 
these medications are not demanded at the market, or 
a manufacturer speci cally limits the number of media-
tors in a speci c geographic region using the selec-
tive distribution and giving the exclusive right to sell its 
goods.
At 52.89 % of medications liquidity ratio range between 
0,15-0,5 is permitted for standards and typical for sales 
of domestic medications, which is mainly performed as 
single, two, or zero level of marketing channel.
40.22 % of medications of soft dosage form with CS 
have liquidity ratio higher than 0,5, it means that the 
price volatility is 50 % and higher. When this ratio is 
higher than 1,0, it means that the range of prices of this 
medication is currently characterized by more than one 
hundred percent difference.
Also it was found the average arithmetic wholesale 
prices for this group of medications during the studied 
period. All SM with corticosteroids (group D 07 accord-
ing to ATC classi cation) were analyzed due to the inter-
national non-patented name and divided into domestic 
and imported medications (Table 1)
Average price for 1 pack of medication of MDF with 
corticosteroids had a signi cant tendency to change a 
price during the period of study. The wholesale price of 
the medication with CS of domestic manufacturer varies 
from UAH 14.02 per pack to 67.43 UAH, while the price 
of imported medication is from 19.89 UAH to 267.35 UAH 
per one pack. It should be noted that the price of import-
ed medications is higher in three times than the price 
of domestic counterparts. For example, we compared 
German medication Soderm and medications of domes-
tic manufacturers such as Betazon (Zdorovya, LLC) and 
Mezoderm (Borshchagivskyy CPF, CJSC). They belong 
to the same group of ATC classi cation (D07AC01) and 
are produced as cream and contain the same amount of 
active pharmaceutical ingredient – betamethasone and 
relatively similar excipients composition, but prices differ 
Fig. 2. The data value of liquidity ratios of SM with corticosteroids
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pack





price, UAH per 
one pack
D07AA02 Hydrocortisone - - 1 25,12
D07AA03 Prednisolone 1 18,04 1 19,89
D07AB02 Hydrocortisone 
butyrate 
- - 5 109,03
D07AB09 Triamcinolone 1 20,45 1 84,02
D07AB10 Alklometazon - - 2 81,30
D07AС01 Betamethasone 3 37,52 3 82,61
D07AС04 Fluocinolone 
Acetonide
2 14,02 3 48,66
D07AС13 Mometasone 2 53,80 7 164,53
D07AС14 Methylprednisolone 
aceponate
2 54,23 2 131,19
D07AС17 Fluticasone - - 2 84,21
D07AС18 Prednicarbate - - 2 87,25
D07AD01 Clobetasol 1 37,72 8 71,77
D07BB01 Flumethasone and 
Antiseptics
- - 1 71,85
D07BB03 Triamcinolone and 
Antiseptics
1 41,70 - -
D07BC01 Betamethasone and 
Antiseptics
- - 1 267,35
D07CA01 Hydrocortisone and 
Antibiotics
- - 5 83,17
D07CC01 Betamethasone and 
Antibiotics
3 67,43 10 134,40
D07CC04 Beclometasone and 
Antibiotics
- - 1 127,60
D07CC05 Flumethasone and 
Antibiotics
1 38,03 - -
D07XA02 Prednisolone 1 23,86 1 171,86
D07XC01 Betamethasone 2 49,92 2 116,32
D07CC03 Mometasone 1 56,98 1 210,75
signi cantly. So, during the analyzed period the average 
wholesale price of medication Soderm is 104.42 UAH, 
Mezoderm – 40.97 UAH, Betazon – UAH 38.75 respec-
tively.
Among the companies which offer at Ukrainian phar-
maceutical market corticosteroids medications (D 07A), 
during the studied period the highest average prices are 
for certain medications of the subgroup D07AA – corti-
costeroids with low activity (group I) and D07AB – mod-
erately active corticosteroids (group II), in particular: 
Lokoyid cream and Lokoyid Lipokrem ointment (manu-
factured in Italy) (Fig. 3).
During the researched period, for subgroup of cor-
ticosteroids D07AC – active corticosteroids (group III) 
and D 07AD – highly active corticosteroids (group IV) 
the highest average price are for the following medi-
cation: cream Tselestoderm –B of Belgian company 
Schering-Plough Labo N.B. and Momat cream of In-
dian company HlenmarkPharmacuticals LTD . These 
medications belong to the category of high-costed 
medication (Fig. 4).
The maximum price for the medication Momat cream 
was observed in February 2015 and Tselestoderm-B 
had high price in the period of January-March.
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Fig. 3. Dynamics of change of average wholesale prices of medication for subgroup D07AA – corticosteroids with low 
activity (group I) and D07AB – moderately active corticosteroids (group II).
Fig. 4. Dynamics of change of average wholesale prices of medication for subgroup D07AC – active corticosteroids 
(group III) and also subgroup D07AD – highly active corticosteroids (group IV).
Farmas ‘yutykalz LTD.
Conclusions
1. The domestic market of SM used in dermatology 
has been analyzed and it was found that for the date 
of January 1, 2015, 226 medications were registered in 
Ukraine, of which 80 SM with corticosteroids are pro-
duced in the form of ointments and creams.
2. It was determined that 73.56 % of all SM with corti-
costeroids are of foreign manufacturers, the main importing 
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countries are Poland – 21.87 %, India – 14.06 %, Italy – 
12.5 %, Germany – 10.93 % Belgium and Croatia 9.37 % 
each. The leading domestic manufacturers of SM with cor-
ticosteroids are Pharmaceutical Company Zdorovya, LLC; 
Farmak, JSC, Pharmaceutical company Darniysa, PJSC; 
and Kyivmedpreparat, JSC of Arteriuum Corporation.
3. The market pricing environment of SM for derma-
tological disease treatment was investigated at the pe-
riod of January-May 2015. It was found that the average 
price per 1 pack of medication had a signi cant tendency 
to change over the researched period. SM with corticos-
teroids of import manufacture are more expensive than 
domestic counterparts.
4. Indicators of price liquidity for 62.89 % of the stud-
ied medications are not higher than 0.5, which is accept-
able to consumers.
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АНАЛІЗ РИНКУ ТА МОНІТОРИНГ ЦІН НА ЛІКАРСЬКІ ЗАСОБИ З КОРТИКОСТЕРОЇДАМИ М’ЯКОЇ 
ФОРМИ ВИПУСКУ, ЩО ВИКОРИСТОВУЮТЬСЯ В ДЕРМАТОЛОГІЇ
Б. В. Вонс, М. Б. Чубка, Т. А. Грошовий
Тернопільський державний медичний університет імені І. Я. Горбачевського
Резюме: досліджено асортимент м’яких лікарських засобів з кортикостероїдами, які використовують у 
дерматології. Визначено співвідношення лікарських засобів вітчизняного та іноземного виробництва в межах кожної 
фармакотерапевтичної підгрупи лікарських препаратів. Проаналізовано ціновий діапазон, розраховано коефіцієнт 
ліквідності для препаратів даної категорії.
Ключові слова: кортикостероїди, м’які лікарські форми, моніторинг цін, маркетингові дослідження.
АНАЛИЗ РЫНКА И МОНИТОРИНГ ЦЕН НА ЛЕКАРСТВЕННЫЕ СРЕДСТВА С 
КОРТИКОСТЕРОИДАМИ МЯГКОЙ ФОРМЫ ВЫПУСКА, ПРИМЕНЯЕМЫЕ В ДЕРМАТОЛОГИИ 
Б. В. Вонс, М. Б. Чубка, Т. А. Грошовый
Тернопольский государственный медицинский университет имени И. Я. Горбачевского
Резюме: исследовано ассортимент мягких лекарственных средств с кортикостероидами, которые используют в 
дерматологии. Определено соотношение лекарственных средств отечественного и иностранного производства в 
пределах каждой фармакотерапевтической подгруппы лекарственных препаратов. Проанализировано ценовой 
диапазон, рассчитан коэффициент ликвидности для препаратов данной категории.
Ключевые слова: кортикостероиды, мягкие лекарственные формы, мониторинг цен, маркетинговые исследования.
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